US20050244811A1 - Matrix array nanobiosensor - Google Patents

Matrix array nanobiosensor Download PDF

Info

Publication number
US20050244811A1
US20050244811A1 US11/011,645 US1164504A US2005244811A1 US 20050244811 A1 US20050244811 A1 US 20050244811A1 US 1164504 A US1164504 A US 1164504A US 2005244811 A1 US2005244811 A1 US 2005244811A1
Authority
US
United States
Prior art keywords
nanobiosensors
array
carbon nanotubes
biological entity
electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/011,645
Inventor
Prabhu Soundarrajan
Valerie Ginsberg
Zvi Yaniv
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Nanotech Holdings Inc
Original Assignee
Applied Nanotech Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/952,669 external-priority patent/US7399400B2/en
Application filed by Applied Nanotech Holdings Inc filed Critical Applied Nanotech Holdings Inc
Priority to US11/011,645 priority Critical patent/US20050244811A1/en
Assigned to NANO-PROPRIETARY, INC. reassignment NANO-PROPRIETARY, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GINSBERG, VALERIE, SOUNDARRAJAN, PRABHU, YANIV, ZVI
Priority to KR1020067013860A priority patent/KR20070004572A/en
Priority to PCT/US2004/042021 priority patent/WO2005074467A2/en
Priority to JP2006544124A priority patent/JP2007513357A/en
Priority to EP04821308A priority patent/EP1706130A4/en
Publication of US20050244811A1 publication Critical patent/US20050244811A1/en
Priority to TW94143909A priority patent/TWI406940B/en
Assigned to APPLIED NANOTECH HOLDINGS, INC. reassignment APPLIED NANOTECH HOLDINGS, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: NANO-PROPRIETARY, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438Electrodes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11CSTATIC STORES
    • G11C13/00Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
    • G11C13/0002Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using resistive RAM [RRAM] elements
    • G11C13/0009RRAM elements whose operation depends upon chemical change
    • G11C13/0014RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material
    • G11C13/0019RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material comprising bio-molecules

Definitions

  • the present invention relates in general to biological sensors, and in particular, to biological sensors arranged in a matrix array.
  • a two enzyme biosensor array for characterization of wastewaters incorporating tyrosinase and horseradish peroxidase (HRP) or cholinesterase-modified electrodes were combined on the same array (Analytical and Bioanalytical Chemistry, Vol. 376, Issue 7, 2003, p. 1098). The performances of bi-enzyme biosensor arrays in the batch mode and in the flow-injection system were discussed.
  • Pin printed biosensor arrays were reported by pin printing protein-doped xerogels (Cho, Eun Jeong; Tao, Zunyu; Tehan, Elizabeth C.; Bright, Frank V., Analytical Chemistry (2002), 74(24), 6177-6184).
  • the sensor was able to detect glucose and oxygen simultaneously.
  • the overall array-to-array response reproductibilities are around 12%, which limits the long time stability of the sensor.
  • FIG. 1 illustrates an embodiment of the present invention
  • FIG. 2 illustrates an embodiment of the present invention
  • FIG. 3 illustrates electronic circuitry for input and output of information from embodiments of the present invention
  • FIG. 4 illustrates responses from nine sensor elements
  • FIG. 5 illustrates responses of embodiments of the present invention
  • FIG. 6 illustrates a response of a matrix biosensor towards ascorbic acid
  • FIG. 7 illustrates a graph of responses of an exemplary embodiment of the present invention
  • FIGS. 8-9 illustrate graphs of operation of a sensor configured in accordance with the present invention.
  • FIG. 10 illustrates an alternative embodiment of the present invention
  • FIGS. 11A and 11B illustrate further details of an alternative embodiment of the present invention
  • FIG. 12 illustrates a matrix array embodiment of the present invention
  • FIG. 13 illustrates active circuits for addressing embodiments of the present invention in an array
  • FIG. 14 illustrates a matrix array configuration in accordance with an embodiment of the present invention.
  • FIG. 15 illustrates an alternative embodiment of the present invention.
  • FIGS. 1-2 One embodiment of the present invention illustrated in FIGS. 1-2 is a matrix array nanobiosensor for monitoring nine analytes, comprising carbon nanotubes, conducting polymers, biological enzymes, nanoparticles and other nanoscale materials as sensor elements (working electrodes) built in a three electrode electrochemical system.
  • the sensor element is miniaturized sufficiently to operate with very small amounts of analyte and applicable to sensitive applications.
  • An inexpensive photolithographic fabrication process is employed for substrate preparation, and the sensor has miniaturized electronics that can couple between the individual nine electrodes for efficient detection.
  • the sensor may find applications in domains like metabolic monitoring (glucose, lactose, fructose, urea, uric acid, phenol, alcohols, ascorbic acid, hydrogen peroxide, phospholipids and other metabolites), chemical warfare detection (sarin, tabun, soman, hydrogen cyanide, cyanogens chloride, mustard, chlorine and other chemical warfare agents), biological warfare agents (ricin, polypeptides and others), potential chemical biological warfare agents (PCB's such as organophosphates, DMMP, malathion, ethion, parathion, paraozon and others), DNA hybridization, gas monitoring (toxic gases like CO, SO 2 , NO, NO 2 , NH 3 , H 2 S and others), and metals (mercury, arsenic and others).
  • the matrix nanobiosensor can be used to detect both gases and liquid multiple analytes.
  • step a using chemical vapor deposition (CVD), 1 ⁇ m of silica dioxide is deposited onto a silica wafer (step a).
  • a shadow mask (step b) having a desired pattern is placed onto the substrate, and 100 ⁇ of chromium, then 500 ⁇ of gold are deposited via electron beam deposition (step c).
  • the shadow mask is removed (step d).
  • step e By the process of CVD, 0.3 ⁇ m of silica nitride is deposited (step e).
  • the substrate is coated with photo-resist (step f).
  • step g a photolithographic process is used to pattern the substrate (step h).
  • the exposed silica nitride (SiI 3 N 4 ) pattern is removed via reactive ion etching (RIE) (step i).
  • RIE reactive ion etching
  • the photo-resist is removed (step j), and Ag/AgCl paste (obtained from Gwent Electronic Materials Ltd, U.K) is screen-printed onto the reference electrode pattern (step k).
  • the Ag/AgCl can also be electrodeposited as a layer of silver at ⁇ 200 mV followed by a chloride layer at +200 mV through potentiostatic methods. Electrical contacts are then soldered onto each electrode (step l).
  • the matrix nanobiosensor substrate developed by photolithography fabrication as described in FIG. 1 ( l ) is as shown in step (l) of FIG. 2 , with nine individual working electrodes 201 , a reference electrode 203 (screen printed Ag/AgCl paste) and a counter electrode 202 (gold).
  • step 2 the carbon nanotubes (CNT) 204 are dispensed (sprayed or screen printed) onto the nine working electrodes 201 using a suitable mask (not shown).
  • Carbon nanotube paste electrodes (0.5 cm 2 ) were prepared by mixing 50% by weight of carbon nanotubes with 43% by weight of organic (or inorganic) vehicle and 7% by weight of glass frit in a mortar and pestle for 30 minutes followed by grinding in a three roll mill for 20 minutes to disperse the clusters in the mixture.
  • the inorganic vehicle was purchased from Cotronics Corp., Brooklyn, N.Y., USA.
  • the substrate was then baked at 100° C. for 10 minutes in an oven and cooled at room temperature. Different weight percentages of carbon nanotubes can also be employed for the electrode preparation.
  • the prepared carbon nanotube paste electrodes can be fired (hard baked) to remove the organic vehicle and activated using a tape.
  • Carbon nanotube spray electrodes (0.5 cm 2 ) were prepared by dissolving a known quantity of carbon nanotubes (e.g., 0.1 g) in 20 ml isopropyl alcohol, followed by ultrasonication for 5 minutes, and spraying the solution onto the substrate (silicon substrate, vacuum evaporated with 20 ⁇ chromium and 500 ⁇ gold). The spray electrode was then baked at 100° C. for 10 minutes in an oven and cooled at room temperature.
  • the carbon nanotubes that can be used with this invention can also be prepared by a chemical vapor deposition process including a catalyst (e.g., nickel, copper, cobalt, iron) and a carbon source (e.g., acetylene, ethylene, methane and other hydrocarbons), or other methods known to one skilled in the art.
  • a catalyst e.g., nickel, copper, cobalt, iron
  • a carbon source e.g., acetylene, ethylene, methane and other hydrocarbons
  • step 3 the electrochemical polymerization and enzyme immobilization was carried onto the carbon nanotube electrodes in situ (applicable to all the electrodes discussed above) by the oxidation of aniline (0.1 M), 1 mg/ml of different biological enzymes 205 in a solution containing 0.2 M H 2 SO 4 in a pH 7.0 buffer solution (note that the enzyme solution preparation varies for different enzymes based on the activity of the enzyme at a particular pH).
  • a potential window of ⁇ 1 V to 1 V was employed for the electropolymerization and immobilization with a scan rate of 50 mV/s for 10 cycles.
  • the different enzymes 205 employed for the nine sensor elements 201 can be selected with regards to the specific analyte in Table 1, though the enzyme systems that can be used in the matrix nanobiosensors are not limited to the list in Table 1.
  • Electropolymerization and enzyme immobilization of polypyrrole and these enzymes was carried out by the oxidation of pyrrole (0.1 M) in a solution containing 0.1 M NaClO 4 in a pH 7.0 buffer solution under the same electrochemical conditions. The electrodes were then washed with water and dried in air.
  • Other conducting polymers can also be employed in these matrix nanobiosensors.
  • other biological entities such as antibodies, nucleic acids, aptamers, etc., can be immobilized onto the nanotubes using similar methods.
  • step 4 the sensor element is placed in a suitable electronic housing and coupled to external electronics by electrodes 206 .
  • the sensor element is also filled with an electrolye necessary for the specific electrochemical reaction based on the analyte (liquid or gaseous) to be detected.
  • the nine working electrodes 201 , counter electrode 202 and reference electrodes 203 are coupled to the drive electronics (discussed below), which is a potentiostatic circuit necessary for any three electrode electrochemical system.
  • the proposed electronics to connect to the above-described array consists of a multi-channel sensor driver. It is capable of operating in either pulsed or continuous scan modes, uses a low-power microprocessor and is programmable.
  • the processor drives signals out to a D/A converter that drives all sensors and a D/A converter that reads sensor outputs.
  • Software in the processor computes the present background currents and runs an algorithm to detect peaks above the expected background. The peaks are compared with patterns for known analytes, after being first corrected for chemistry-induced peak shifts. Results are presented in both qualitative and quantitative output channels.
  • the quantitative channel will be optional, with presence of an analyte indicated by LED display or other suitable devices. False positives/negatives can be efficiently eliminated due to the peak current at a unique redox potential of the analyte which presents a considerable improvement over simple resistive based sensors arrays.
  • the components of the electronic assembly may be as follows:
  • the electrometer circuit 301 measures the voltage difference between the reference 203 and working 201 electrodes. Its output has two major functions: it is the feedback signal in the potentiostat circuit, and it is the signal that is measured whenever the cell voltage is needed.
  • An ideal electrometer has zero input current and infinite input impedance. Current flow through the reference electrode 203 can change its potential. In practice, all modern electrometers have input currents close enough to zero that this effect can usually be ignored.
  • Two important electrometer characteristics are its bandwidth and its input capacitance.
  • the electrometer bandwidth characterizes the AC frequencies the electrometer 301 can measure when it is driven from a low impedance source. The electrometer bandwidth is higher than the bandwidth of the other electronic components in the potentiostat.
  • the electrometer input capacitance and the reference electrode resistance form an RC filter. If this filter's time constant is too large, it can limit the effective bandwidth of the electrometer and cause system instabilities. Smaller input capacitance translates into more stable operation and greater tolerance for high impedance reference electrodes.
  • the current to voltage (I/E) converter 302 in the simplified schematic measures the cell current. It forces the cell current to flow through a current measurement resistor, Rm. The voltage drop across Rm is a measure of the cell current.
  • Rm current measurement resistor
  • a number of different Rm resistors can be switched into the I/E circuit 302 under computer control. This allows measurement of widely varying of currents, with each current measured on using an appropriate resistor.
  • An “I/E autoranging” algorithm is often used to select the appropriate resistor values.
  • the I/E converter's bandwidth depends strongly on its sensitivity. Measurement of small currents requires large Rm values. Stray (unwanted) capacitance in the I/E converter 302 forms an RC filter with Rm, limiting the I/E bandwidth.
  • the control amplifier 303 is a servo amplifier. It compares the measured cell voltage with the desired voltage and drives current into the cell to force the voltages to be the same. Note that the measured voltage is input into the negative input of the control amplifier 303 . A positive perturbation in the measured voltage creates a negative control amplifier output. This negative output counteracts the initial perturbation. This control scheme is known as negative feedback. Under normal conditions, the cell voltage is controlled to be identical to the signal source voltage.
  • the signal circuit 304 is a computer controlled voltage source. It is generally the output of a digital to analog (D/A) converter (see DAC in FIG. 15 ) that converts computer generated numbers into voltages. Proper choice of number sequences allows the computer to generate constant voltages, voltage ramps, and even sine waves at the signal circuit output.
  • D/A converter digital to analog converter
  • the waveform is a digital approximation of the equivalent analog waveform. It contains small voltage steps. The size of these steps is controlled by the resolution of the D/A converter and the rate it at which it is being updated with new numbers.
  • the qualitative sensing is achieved by cyclic voltammetry, which is used to characterize the unique amperometric oxidative potential.
  • the quantitative sensing is carried out by chronoamperometric measurements at the fixed characteristic potential determined by cyclic voltammetry.
  • the liquid phase sensors require a small amount of analyte (in micromolar range) and the gas phase sensors are provided with a hydrophobic membrane and a liquid or solid electrolyte.
  • the solid electrolyte can be any anionic exchange membrane (e.g., nafion), nanoporous silica (e.g., xerogels, hydrogels).
  • the enzymes may be immobilized into the nanotubes using a cyclic voltammetric (CV) technique (here the voltage is varied in steps, typically swept between ⁇ 1V to +1V and reverse for one loop).
  • CV cyclic voltammetric
  • E may be immobilized onto the sensor elements using CV to form the sensor array.
  • the nine different enzymes are selected to have a unique reaction with nine different analytes (A) [example: Glucose oxidase (E) for glucose (A)].
  • the matrix is turned on by the electronics (the background electrochemical process in the electronics is CV) and the CV has a unique redox peak for each of the analytes resulting from the enzyme (E) vs analyte (A) reaction. Based on the redox peak for each analyte obtained, the software calibrates the concentration levels of the analyte.
  • Chronoamperometry operates by fixing a constant voltage and gives out current vs time plots. A characteristic voltage is fixed for each analyte obtained from the previous CV run. An advantage of this technique is that the measurements can be done real time and faster compared to the scan method in the CV.
  • Equation (1) The response of the matrix nanobiosensor towards hydrogen peroxide is shown in equation (1) below. As an example, ten enzymatic schemes are illustrated. It can be seen than hydrogen peroxide is a by-product of the enzymatic reaction in equations (2) through (6).
  • FIG. 4 The response of the individual nine elements of the matrix nanobiosensor towards hydrogen peroxide is shown in FIG. 4 . While pristine carbon nanotubes can oxidize hydrogen peroxide, the presence of an enzyme and the conducting polymer is a requirement for enzymatic biosensing applications according to the present invention. As can be seen, there is a small variation in the peak responses and amperometric oxidation voltages in the nine individual elements, but the anodic oxidation potential is still much lower than reported in the literature. Previous reports indicate the development of glucose sensors by the addition of palladium, copper, iridium or ruthenium into carbon paste electrodes with glucose oxidase. (S. A. Miscoria, G. D. Barrera, G. A.
  • Rivas; Electroanalysis, 14, 300, 2003), and phenol sensors with the incorporation of iridium microparticles into carbon paste matrices with polyphenol oxidase M. D. Rubianes, G. A. Rivas, Electroanalysis, 12, 1159. These approaches do not incorporate a conducting polymer matrix and involve the mechanical mixing of the enzyme into the carbon paste matrix.
  • Enzymatic schemes illustrated in equations (7) to (10) do not release hydrogen peroxide as a result of biochemical reaction, but the analytes can be detected by monitoring other products namely dehydroascorbic acid (ascorbic oxidase ⁇ 7), glutamate (L-glutamic dehydrogenase ⁇ 8), CO 2 (formate dehydrogenase ⁇ 9), quinone (polyphenol oxidase ⁇ 10).
  • This invention is not limited to the ten enzymes illustrated in the reaction schemes or in Table 1, but any redox active enzyme systems can be implemented.
  • the cyclic voltammogram of the polymerization of aniline (0.1 M in 0.2 M H 2 SO 4 ) in situ with ascorbic acid (equation (7)) onto the carbon nanotube electrode is shown in FIG. 5 .
  • the response of the peak response current (0.6 V) due to the oxidation of ascorbic acid into dehydroascorbic acid is shown in FIG. 6 .
  • the selectivity of the sensor is illustrated in FIG. 7 , where the oxidative peaks are clearly distinguishable for hydrogen peroxide. This eliminates interference from ascorbic acid and also provides higher selectivity.
  • the matrix nanobiosensor did not have any interference from consecutive sensor elements, though different enzymes are immobilized onto nine individual elements.
  • the matrix nanobiosensor array was stable over a number of assays (over hundred assays), the lifetime of the sensor is a function of the activities of the enzyme.
  • the conducting polymer matrix in the nanobiosensor provides a good stability for the enzymes in the nanotube matrix.
  • the specific enzyme stability based on its biochemical activity is given in Table 2. Further, the enzyme stabilization can extend the lifetime of the sensors.
  • the working electrode is composed of a nanostructured platinum material namely platinum nanoparticles or carbon nanotubes electroplated with platinum nanoparticles.
  • the main reason for the employment of platinum as the working electrode is its known catalytic oxidation of carbon monoxide.
  • the coating of the platinum nanoparticles onto the carbon nanotubes increases the surface catalytic activity of the working electrode towards CO yielding a higher sensitivity.
  • the counter electrode is composed of a metal (e.g., platinum, gold, etc.) and the reference electrode (e.g., Ag/AgCl).
  • the electrolyte constitutes a strong acidic electrolyte (e.g., M H 2 SO 4 ), and the sensor is enclosed in a hydrophilic semi-permeable membrane.
  • FIG. 8 The cyclic voltammogram of the oxidation of CO at platinum electrodes using the sensor is shown in FIG. 8 , wherein the lower curve does not show a characteristic peak due to the absence of CO.
  • FIG. 9 describes the chronoamperometric response of the sensor to the exposure of CO. The sensor has a quick response time and provides reliable measurements since the oxidation peak of 0.85 V is characteristic towards the oxidation of CO by platinum.
  • the embodiments discussed above describe the fabrication of a nine element matrix for the development of nanobiosensors.
  • the previous design electronics incorporated the individual driving of each sensor element along with the reference and counter electrodes. Though the design is a good development over the single element biosensor, there may be some difficulty extending this design for the development of n ⁇ n sensor elements.
  • the previous design also incorporated a planar structure, wherein the reference, counter and working electrodes are in a silicon chip oriented on the X-Y plane.
  • the nanobiosensor can be extended to detect hundreds of analytes if the biosensor substrate is linear. There is a requirement of an optimized design and electronic driving to extend the diversity of the nanobiosensors.
  • the sensor electronics enable cyclic voltammetric and chroamperometric measurements in the sensor without the standard laboratory based potentiostat.
  • Electrochemical sensors with three electrode systems operate in an electrolyte coupled with an external potentiostat (see FIG. 3 ).
  • Various designs have been reported for the electrochemical based sensors, but limited effort has been devoted to the development of array based sensors for the detection of multiple analytes.
  • the problems with multi-sensor arrays are the cross-interference from other compounds, stability of the sensor element, etc.
  • Biosensors have been reported using capture reagents. Devices and methods for detecting analytes using electrosensor having capture reagents, (World patent, WO0138873, 2001) but limited to the detection of a single analyte.
  • U.S. Pat. No. 6,656,712 describes the attachment of proteins to carbon nanotubes by incubation, without stirring.
  • the biological macromolecule in solution is attached to the carbon nanotubes closed at their ends, under suitable temperature and pH conditions.
  • the present invention uses an approach for the attachment of macromolecules, enzymes, proteins, antibodies, aptamers, nucleic acids, antigens, DNA, aptamers, ribozomes that includes electropolymerization with a conducting polymer matrix.
  • An array of such sensors can be carried out within a few minutes and gives a stable framework for the electrochemical/biochemical reactions.
  • the present invention also provides an efficient method of detection of both gaseous and liquid analytes by the use of a hydrophobic, semi-permeable membrane.
  • the electrolyte can be wet (liquid phase) or dry (nafion, nanostructured silica, hydrogels and others) for the detection of chemical, biological warfare agents, gas detection, metabolic monitoring and other applications.
  • FIGS. 10, 11A and 11 B A design of a linear nanobiosensor in accordance with an embodiment of the present invention is shown in FIGS. 10, 11A and 11 B.
  • FIG. 11A is a top view
  • FIG. 11B is a partial cross-sectional view of one of the electrode assemblies illustrated in FIG. 10 .
  • the sensor element is comprised of carbon nanotubes 1100 , and conducting polymer and biological enzymes 1101 .
  • the sensing element is the working electrode 1104 supported on a silicon substrate 1110 ; other substrates like plastic (polymeric), glass, ceramic, ITO, kapton and printed circuit boards may also be used.
  • An insulating layer used over the bare substrate can be metal nitride, metal oxide, polymer, etc.
  • the reference electrode 1103 can be made up of Ag/AgCl (silver, silver chloride), SCE (standard calomel electrode), SHE (standard hydrogen electrode) or other standard reference electrodes.
  • the counter electrode 1102 can be a conductive layer like gold, silver, copper, titanium, platinum, chromium, aluminum, etc. In the linear structure, insulating supports (not shown) may be provided to separate the reference 1103 , working 1104 and counter 1102 electrodes, since it is necessary for the three electrodes to be separated from each other during the electrochemical process.
  • the invention provides an efficient way for the detection of liquid and gaseous analytes.
  • the gas sensor may use an enclosed semi-permeable, hydrophobic membrane (not shown), which can also be permi-selective to distinguish between different gases (electron donors and electron acceptors).
  • the membrane can be incorporated on the counter/working electrode or can be separated from the system.
  • the purpose of the membrane is to allow a one way entry for the gas into the working electrode for the electrochemical reaction. It is understood that the purpose of the reference electrode 1103 in the three electrode system is to maintain a stable potential around the working electrodes 1104 .
  • FIGS. 10, 11A and 11 B provide a design wherein the counter electrode 1102 is placed in the top of the linear system. It is generally desirable to place the counter electrode 1102 far from the working electrode 1104 , with an area at least ten times that of the working electrode.
  • FIG. 12 shows the top view of an exemplary 3 ⁇ 3 matrix array incorporating nine working electrodes (W 11 to W 33 ) (as described above with respect to FIG. 11 ), with each working electrode configuration driven by a row and a column driver (see FIG. 14 ).
  • the working electrode W 11 is driven by row 1 (R 1 ) and column 1 (C 1 ).
  • the sensor element (each working electrode configuration) also incorporates an active element (AC) for the row-column addressing, wherein R 1 and C 1 should be “turned on” to activate the working electrode W 11 .
  • the active matrix array design enables simultaneous driving of the multiple working electrodes, which cannot be achieved in the linear array design.
  • the voltage sweep of ⁇ 1V to +1V at a scan rate of 50 mV/s in a cyclic voltammetric process takes 80 seconds for one electrode.
  • the design shown in FIG. 2 wherein the working electrodes are arranged in a linear fashion, it would take 12 minutes to read the response of nine analytes. This presents a considerable disadvantage while sensing multiple analytes.
  • FIG. 14 describes an active matrix configuration wherein the simultaneous driving of the working electrodes considerably shorten the time of detection. (For example, 80 seconds operating with cyclic voltammetry within the voltage sweep of ⁇ 1V to +1V at a scan rate of 50 mV/s)”.
  • the active element (AC) is made up on an electrical circuit that can incorporate different configurations as shown in FIG. 13 .
  • the active circuit can constitute two diodes ( FIG. 13 a ), a diode with a resistor connected to the capacitor ( FIG. 13 b ), or a transistor ( FIG. 13 c ).
  • the invention is not limited to the above described active matrix components, but can be extended to any “active” electronic circuit that can address the row-column operation for the matrix array nanobiosensor.
  • Wxy working electrode configuration
  • the active matrix should be connected to a row (Rx) and column (Cy) as shown in FIG. 12 .
  • the active working electrode components should incorporate the reference and the counter electrodes (see FIG. 11 ) for the electrochemical reactions.
  • the electrochemical techniques include but are not limited to cyclic voltammetry, chronoamperometry, differential pulse voltammetry, linear sweep voltammetry, stripping voltammetry, AC voltammetry, AC impedance, etc.
  • the sensor can be used to detect the analyte also by amperometric, potentiometric, conductometric, voltammetric methods or combinations thereof.
  • FIG. 14 shows a cross-section view of an n ⁇ n array matrix nanobiosensor with the row 1401 and column 1402 drivers.
  • the structure incorporates an n ⁇ n array of working electrodes 1104 , each element incorporating the specific carbon nanotube 1100 , conducting polymer, enzyme combination 1101 as described previously.
  • This invention is not limited to the above mixture of components mentioned above but can be employed with carbon (all forms), noble metals (gold, platinum, etc.) and proteins, antibodies, nucleic acids (DNA, RNA), peptides, aptamers, aptazymes, proteins along with the different conducting polymer combinations.
  • the drive electronics for the matrix array nanobiosensor is shown in FIG. 15 .
  • the active matrix array nanobiosensor incorporates a shift register 1401 that couples to the n ⁇ n array of working electrodes 1104 that is coupled to data in, clock and an enable.
  • the working electrode arrays are coupled to a current to voltage (I/E) converter 1402 , the reference electrodes to an electrometer circuit 1403 that is coupled to a control amplifier 1404 connected to the counter electrode 1102 .
  • I/E current to voltage
  • the different components of the electronic circuit for the linear array sensor are similar to that described in FIG. 3 .
  • the reference electrodes 1103 are shown interdigitated with the working electrodes 1104 , but different configurations are possible and are not limited to the invention.
  • the voltage sweep typically used is around ⁇ 1 V to +1 V with a scan rate of 50 mV with a step of 1 mV, though other voltage windows, scan rate and step sizes can be used for cyclic voltammetric measurements.
  • the multi-channel output from the n ⁇ n arrays is coupled to a display device (not shown) or an alarm (not shown) to indicate the presence of the analyte.
  • the design shown in FIG. 15 can be altered to drive n ⁇ n sensor elements simultaneously by building miniaturized circuitry (electrometer, I/E converter, control amplifier) for each of the sensor elements.
  • the row and column drivers shown in FIG. 14 are addressable to any X-Y element in the sensor matrix.
  • Each of the active elements 1405 (AC) can be controlled by a switch 1406 through the row-column addressing.

Abstract

An apparatus for detecting multiple analytes comprising an array of nanobiosensors, each comprising a biological entity immobilized onto carbon nanotubes, wherein a plurality of the nanobiosensors in the array have unique biological entities, wherein a first one of the plurality of nanobiosensors has a first biological entity immobilized onto carbon nanotubes, and wherein a second one of the plurality of nanobiosensors has a second biological entity immobilized onto carbon nanotubes, the first biological entity is unique relative to the second biological entity.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • The present application claims priority to U.S. Provisional Patent Application Ser. Nos. 60/529,683 and 60/531,819, which are hereby incorporated by reference herein. The present application is a continuation-in-part application of U.S. patent application Ser. No. 10/952,669, which is hereby incorporated by reference herein.
  • TECHNICAL FIELD
  • The present invention relates in general to biological sensors, and in particular, to biological sensors arranged in a matrix array.
  • BACKGROUND INFORMATION
  • The simultaneous monitoring for multiple analytes (liquids and gases) has diversified applications in various domains like metabolic monitoring, chemical, biological warfare detection, gas sensing, etc. Most present day sensors have considerable limitations in monitoring more than one analyte due to the problems of cross-sensitivity and interference from other compounds. This limitation is a disadvantage with continuous detection of multiple analytes. Some of the multi-analyte systems do not have sufficient miniaturization for in vivo or other sensitive applications. There is a lack of unified sensor arrays that can monitor both gases and liquids simultaneously.
  • There have been several reports on the development of biosensor arrays using different methodologies. A common biosensor format for an enzyme based biosensor array to monitor fruit quality was reported (Biosensors & Bioelectronics (2003), 18(12), 1429-1437). Pectin was used as the immobilization matrix for the sensors, but the methodology of immobilization was “drop and dry mechanism” which did not yield good sensitivity.
  • A two enzyme biosensor array for characterization of wastewaters incorporating tyrosinase and horseradish peroxidase (HRP) or cholinesterase-modified electrodes were combined on the same array (Analytical and Bioanalytical Chemistry, Vol. 376, Issue 7, 2003, p. 1098). The performances of bi-enzyme biosensor arrays in the batch mode and in the flow-injection system were discussed.
  • A multifunctional bio-sensing chip was reported based on the electrochemiluminescent (ECL) detection of enzymatically produced hydrogen peroxide (Marquette, Christophe A.; Degiuli, Agnes; Blum, Loic J., Biosensors & Bioelectronics (2003), 19(5), 433-439). Six different oxidases specific for choline, glucose, glutamate, lactate, lysine and urate were non-covalently immobilized on in the array sensor but the limit of detection was only towards hydrogen peroxide.
  • Pin printed biosensor arrays (PPBSA) were reported by pin printing protein-doped xerogels (Cho, Eun Jeong; Tao, Zunyu; Tehan, Elizabeth C.; Bright, Frank V., Analytical Chemistry (2002), 74(24), 6177-6184). The sensor was able to detect glucose and oxygen simultaneously. The overall array-to-array response reproductibilities are around 12%, which limits the long time stability of the sensor.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • For a more complete understanding of the present invention, and the advantages thereof, reference is now made to the following descriptions taken in conjunction with the accompanying drawings, in which:
  • FIG. 1 illustrates an embodiment of the present invention;
  • FIG. 2 illustrates an embodiment of the present invention;
  • FIG. 3 illustrates electronic circuitry for input and output of information from embodiments of the present invention;
  • FIG. 4 illustrates responses from nine sensor elements;
  • FIG. 5 illustrates responses of embodiments of the present invention;
  • FIG. 6 illustrates a response of a matrix biosensor towards ascorbic acid;
  • FIG. 7 illustrates a graph of responses of an exemplary embodiment of the present invention;
  • FIGS. 8-9 illustrate graphs of operation of a sensor configured in accordance with the present invention;
  • FIG. 10 illustrates an alternative embodiment of the present invention;
  • FIGS. 11A and 11B illustrate further details of an alternative embodiment of the present invention;
  • FIG. 12 illustrates a matrix array embodiment of the present invention;
  • FIG. 13 illustrates active circuits for addressing embodiments of the present invention in an array;
  • FIG. 14 illustrates a matrix array configuration in accordance with an embodiment of the present invention; and
  • FIG. 15 illustrates an alternative embodiment of the present invention.
  • DETAILED DESCRIPTION
  • In the following description, numerous specific details are set forth such as specific memory array configurations, etc. to provide a thorough understanding of the present invention. However, it will be obvious to those skilled in the art that the present invention may be practiced without such specific details. In other instances, well-known circuits have been shown in block diagram form in order not to obscure the present invention in unnecessary detail. For the most part, details concerning timing considerations and the like have been omitted inasmuch as such details are not necessary to obtain a complete understanding of the present invention and are within the skills of persons of ordinary skill in the relevant art.
  • Refer now to the drawings wherein depicted elements are not necessarily shown to scale and wherein like or similar elements are designated by the same reference numeral through the several views.
  • One embodiment of the present invention illustrated in FIGS. 1-2 is a matrix array nanobiosensor for monitoring nine analytes, comprising carbon nanotubes, conducting polymers, biological enzymes, nanoparticles and other nanoscale materials as sensor elements (working electrodes) built in a three electrode electrochemical system. The sensor element is miniaturized sufficiently to operate with very small amounts of analyte and applicable to sensitive applications. An inexpensive photolithographic fabrication process is employed for substrate preparation, and the sensor has miniaturized electronics that can couple between the individual nine electrodes for efficient detection.
  • The sensor may find applications in domains like metabolic monitoring (glucose, lactose, fructose, urea, uric acid, phenol, alcohols, ascorbic acid, hydrogen peroxide, phospholipids and other metabolites), chemical warfare detection (sarin, tabun, soman, hydrogen cyanide, cyanogens chloride, mustard, chlorine and other chemical warfare agents), biological warfare agents (ricin, polypeptides and others), potential chemical biological warfare agents (PCB's such as organophosphates, DMMP, malathion, ethion, parathion, paraozon and others), DNA hybridization, gas monitoring (toxic gases like CO, SO2, NO, NO2, NH3, H2S and others), and metals (mercury, arsenic and others). The matrix nanobiosensor can be used to detect both gases and liquid multiple analytes.
  • Photolithographic Fabrication of a Matrix Nanobiosensor:
  • Referring to FIG. 1, using chemical vapor deposition (CVD), 1 μm of silica dioxide is deposited onto a silica wafer (step a). A shadow mask (step b) having a desired pattern is placed onto the substrate, and 100 Å of chromium, then 500 Å of gold are deposited via electron beam deposition (step c). The shadow mask is removed (step d). By the process of CVD, 0.3 μm of silica nitride is deposited (step e). The substrate is coated with photo-resist (step f). Using a mask (step g), a photolithographic process is used to pattern the substrate (step h). The exposed silica nitride (SiI3N4) pattern is removed via reactive ion etching (RIE) (step i). The photo-resist is removed (step j), and Ag/AgCl paste (obtained from Gwent Electronic Materials Ltd, U.K) is screen-printed onto the reference electrode pattern (step k). The Ag/AgCl can also be electrodeposited as a layer of silver at −200 mV followed by a chloride layer at +200 mV through potentiostatic methods. Electrical contacts are then soldered onto each electrode (step l).
  • Sensor Fabrication:
  • The matrix nanobiosensor substrate developed by photolithography fabrication as described in FIG. 1(l) is as shown in step (l) of FIG. 2, with nine individual working electrodes 201, a reference electrode 203 (screen printed Ag/AgCl paste) and a counter electrode 202 (gold).
  • In step 2 (FIG. 2), the carbon nanotubes (CNT) 204 are dispensed (sprayed or screen printed) onto the nine working electrodes 201 using a suitable mask (not shown).
  • Carbon nanotube paste electrodes (0.5 cm2) were prepared by mixing 50% by weight of carbon nanotubes with 43% by weight of organic (or inorganic) vehicle and 7% by weight of glass frit in a mortar and pestle for 30 minutes followed by grinding in a three roll mill for 20 minutes to disperse the clusters in the mixture. The inorganic vehicle was purchased from Cotronics Corp., Brooklyn, N.Y., USA. The substrate was then baked at 100° C. for 10 minutes in an oven and cooled at room temperature. Different weight percentages of carbon nanotubes can also be employed for the electrode preparation. The prepared carbon nanotube paste electrodes can be fired (hard baked) to remove the organic vehicle and activated using a tape.
  • Carbon nanotube spray electrodes (0.5 cm2) were prepared by dissolving a known quantity of carbon nanotubes (e.g., 0.1 g) in 20 ml isopropyl alcohol, followed by ultrasonication for 5 minutes, and spraying the solution onto the substrate (silicon substrate, vacuum evaporated with 20 Å chromium and 500 Å gold). The spray electrode was then baked at 100° C. for 10 minutes in an oven and cooled at room temperature.
  • The carbon nanotubes that can be used with this invention can also be prepared by a chemical vapor deposition process including a catalyst (e.g., nickel, copper, cobalt, iron) and a carbon source (e.g., acetylene, ethylene, methane and other hydrocarbons), or other methods known to one skilled in the art.
  • In step 3 (FIG. 2), the electrochemical polymerization and enzyme immobilization was carried onto the carbon nanotube electrodes in situ (applicable to all the electrodes discussed above) by the oxidation of aniline (0.1 M), 1 mg/ml of different biological enzymes 205 in a solution containing 0.2 M H2SO4 in a pH 7.0 buffer solution (note that the enzyme solution preparation varies for different enzymes based on the activity of the enzyme at a particular pH). A potential window of −1 V to 1 V was employed for the electropolymerization and immobilization with a scan rate of 50 mV/s for 10 cycles. The different enzymes 205 employed for the nine sensor elements 201 can be selected with regards to the specific analyte in Table 1, though the enzyme systems that can be used in the matrix nanobiosensors are not limited to the list in Table 1.
    TABLE 1
    Analyte Enzyme
    Glucose Glucose oxidase, Glucose dehydrogenase
    L-Lactate Lactate oxidase, Lactate dehydrogenase
    Phenol, catechol, Tryosinase (polyphenol oxidase)
    p-cresol, m-cresol,
    Atrazine
    Urea Urease
    Ascorbic acid Ascorbic oxidase
    Choloestrol Choloestrol oxidase, Choloestrol dehydrogenase
    Fructose Fructose dehydrogenase
    Lipids, Triglycerides Lipase
    Uric acid Uricase
    Choline, Lecithin Choline oxidase
    Hemoglobin Pepsin
    Glutamate Glutamate oxidase
    Alcohol Alcohol dehydrogenase, Alcohol oxidase
    Carbon monoxide Carbon monoxide dehydrogenase
    Sucrose Invertase, mutarotse
    Malate Malate oxidase, NADH oxidase
    Lycine Lycine oxidase
    Glycerol Glycerol dehydrogenase
    Citrate and pyruvic Citrate lyase and pyruvate oxidase
    acid
    Sulphite Sulphite oxidase
    Gelatinized starch Amyloglucosidase, α-amylase, glucose oxidase
    Penicillin Immobilized penicillin
    Tannin Laccase
    Formate Formate dehydrogenase
    Hydrogen peroxide Horseradish peroxidase
  • Electropolymerization and enzyme immobilization of polypyrrole and these enzymes was carried out by the oxidation of pyrrole (0.1 M) in a solution containing 0.1 M NaClO4 in a pH 7.0 buffer solution under the same electrochemical conditions. The electrodes were then washed with water and dried in air. Other conducting polymers can also be employed in these matrix nanobiosensors. Additionally, other biological entities such as antibodies, nucleic acids, aptamers, etc., can be immobilized onto the nanotubes using similar methods.
  • In step 4 (FIG. 2), the sensor element is placed in a suitable electronic housing and coupled to external electronics by electrodes 206. The sensor element is also filled with an electrolye necessary for the specific electrochemical reaction based on the analyte (liquid or gaseous) to be detected. The nine working electrodes 201, counter electrode 202 and reference electrodes 203 are coupled to the drive electronics (discussed below), which is a potentiostatic circuit necessary for any three electrode electrochemical system.
  • Electronic Drive Assembly:
  • Referring to FIG. 3, the proposed electronics to connect to the above-described array consists of a multi-channel sensor driver. It is capable of operating in either pulsed or continuous scan modes, uses a low-power microprocessor and is programmable. The processor drives signals out to a D/A converter that drives all sensors and a D/A converter that reads sensor outputs. A controlled-impedance op-amp for each sensor, with multiplexer, handles the periodic reading of each of the sensors in turn. Software in the processor computes the present background currents and runs an algorithm to detect peaks above the expected background. The peaks are compared with patterns for known analytes, after being first corrected for chemistry-induced peak shifts. Results are presented in both qualitative and quantitative output channels. In the final system, the quantitative channel will be optional, with presence of an analyte indicated by LED display or other suitable devices. False positives/negatives can be efficiently eliminated due to the peak current at a unique redox potential of the analyte which presents a considerable improvement over simple resistive based sensors arrays. The components of the electronic assembly may be as follows:
  • (a) The Electrometer
  • The electrometer circuit 301 measures the voltage difference between the reference 203 and working 201 electrodes. Its output has two major functions: it is the feedback signal in the potentiostat circuit, and it is the signal that is measured whenever the cell voltage is needed. An ideal electrometer has zero input current and infinite input impedance. Current flow through the reference electrode 203 can change its potential. In practice, all modern electrometers have input currents close enough to zero that this effect can usually be ignored. Two important electrometer characteristics are its bandwidth and its input capacitance. The electrometer bandwidth characterizes the AC frequencies the electrometer 301 can measure when it is driven from a low impedance source. The electrometer bandwidth is higher than the bandwidth of the other electronic components in the potentiostat. The electrometer input capacitance and the reference electrode resistance form an RC filter. If this filter's time constant is too large, it can limit the effective bandwidth of the electrometer and cause system instabilities. Smaller input capacitance translates into more stable operation and greater tolerance for high impedance reference electrodes.
  • (b) The Current to Voltage Converter
  • The current to voltage (I/E) converter 302 in the simplified schematic measures the cell current. It forces the cell current to flow through a current measurement resistor, Rm. The voltage drop across Rm is a measure of the cell current. A number of different Rm resistors can be switched into the I/E circuit 302 under computer control. This allows measurement of widely varying of currents, with each current measured on using an appropriate resistor. An “I/E autoranging” algorithm is often used to select the appropriate resistor values. The I/E converter's bandwidth depends strongly on its sensitivity. Measurement of small currents requires large Rm values. Stray (unwanted) capacitance in the I/E converter 302 forms an RC filter with Rm, limiting the I/E bandwidth.
  • (c) The Control Amplifier
  • The control amplifier 303 is a servo amplifier. It compares the measured cell voltage with the desired voltage and drives current into the cell to force the voltages to be the same. Note that the measured voltage is input into the negative input of the control amplifier 303. A positive perturbation in the measured voltage creates a negative control amplifier output. This negative output counteracts the initial perturbation. This control scheme is known as negative feedback. Under normal conditions, the cell voltage is controlled to be identical to the signal source voltage.
  • (d) The Signal
  • The signal circuit 304 is a computer controlled voltage source. It is generally the output of a digital to analog (D/A) converter (see DAC in FIG. 15) that converts computer generated numbers into voltages. Proper choice of number sequences allows the computer to generate constant voltages, voltage ramps, and even sine waves at the signal circuit output. When a D/A converter is used to generate a waveform such as a sine wave or a ramp, the waveform is a digital approximation of the equivalent analog waveform. It contains small voltage steps. The size of these steps is controlled by the resolution of the D/A converter and the rate it at which it is being updated with new numbers.
  • Mechanism of Sensing:
  • One of the mechanisms of sensing as described previously is electrochemical based. The qualitative sensing is achieved by cyclic voltammetry, which is used to characterize the unique amperometric oxidative potential. The quantitative sensing is carried out by chronoamperometric measurements at the fixed characteristic potential determined by cyclic voltammetry. The liquid phase sensors require a small amount of analyte (in micromolar range) and the gas phase sensors are provided with a hydrophobic membrane and a liquid or solid electrolyte. The solid electrolyte can be any anionic exchange membrane (e.g., nafion), nanoporous silica (e.g., xerogels, hydrogels).
  • The enzymes may be immobilized into the nanotubes using a cyclic voltammetric (CV) technique (here the voltage is varied in steps, typically swept between −1V to +1V and reverse for one loop). Nine different enzymes (E) may be immobilized onto the sensor elements using CV to form the sensor array. The nine different enzymes are selected to have a unique reaction with nine different analytes (A) [example: Glucose oxidase (E) for glucose (A)]. When the analyte comes in contact with the sensor, the matrix is turned on by the electronics (the background electrochemical process in the electronics is CV) and the CV has a unique redox peak for each of the analytes resulting from the enzyme (E) vs analyte (A) reaction. Based on the redox peak for each analyte obtained, the software calibrates the concentration levels of the analyte.
  • Chronoamperometry operates by fixing a constant voltage and gives out current vs time plots. A characteristic voltage is fixed for each analyte obtained from the previous CV run. An advantage of this technique is that the measurements can be done real time and faster compared to the scan method in the CV.
  • The response of the matrix nanobiosensor towards hydrogen peroxide is shown in equation (1) below. As an example, ten enzymatic schemes are illustrated. It can be seen than hydrogen peroxide is a by-product of the enzymatic reaction in equations (2) through (6).
    Figure US20050244811A1-20051103-C00001
  • The response of the individual nine elements of the matrix nanobiosensor towards hydrogen peroxide is shown in FIG. 4. While pristine carbon nanotubes can oxidize hydrogen peroxide, the presence of an enzyme and the conducting polymer is a requirement for enzymatic biosensing applications according to the present invention. As can be seen, there is a small variation in the peak responses and amperometric oxidation voltages in the nine individual elements, but the anodic oxidation potential is still much lower than reported in the literature. Previous reports indicate the development of glucose sensors by the addition of palladium, copper, iridium or ruthenium into carbon paste electrodes with glucose oxidase. (S. A. Miscoria, G. D. Barrera, G. A. Rivas; Electroanalysis, 14, 300, 2003), and phenol sensors with the incorporation of iridium microparticles into carbon paste matrices with polyphenol oxidase (M. D. Rubianes, G. A. Rivas, Electroanalysis, 12, 1159). These approaches do not incorporate a conducting polymer matrix and involve the mechanical mixing of the enzyme into the carbon paste matrix.
  • Enzymatic schemes illustrated in equations (7) to (10) do not release hydrogen peroxide as a result of biochemical reaction, but the analytes can be detected by monitoring other products namely dehydroascorbic acid (ascorbic oxidase −7), glutamate (L-glutamic dehydrogenase −8), CO2 (formate dehydrogenase −9), quinone (polyphenol oxidase −10). This invention is not limited to the ten enzymes illustrated in the reaction schemes or in Table 1, but any redox active enzyme systems can be implemented. As an example, the cyclic voltammogram of the polymerization of aniline (0.1 M in 0.2 M H2SO4) in situ with ascorbic acid (equation (7)) onto the carbon nanotube electrode is shown in FIG. 5. The response of the peak response current (0.6 V) due to the oxidation of ascorbic acid into dehydroascorbic acid is shown in FIG. 6. The selectivity of the sensor is illustrated in FIG. 7, where the oxidative peaks are clearly distinguishable for hydrogen peroxide. This eliminates interference from ascorbic acid and also provides higher selectivity.
  • Similar results were obtained for other enzymatic systems. The matrix nanobiosensor did not have any interference from consecutive sensor elements, though different enzymes are immobilized onto nine individual elements.
  • Stability of the Matrix Nanobiosensor:
  • The matrix nanobiosensor array was stable over a number of assays (over hundred assays), the lifetime of the sensor is a function of the activities of the enzyme. The conducting polymer matrix in the nanobiosensor provides a good stability for the enzymes in the nanotube matrix. The specific enzyme stability based on its biochemical activity is given in Table 2. Further, the enzyme stabilization can extend the lifetime of the sensors.
    TABLE 2
    Length of
    Stability Storage Temperature (° C.) and Application
    Biological enzyme (Days) Domains
    Acetylcholinesterase 76 37
    Pesticide detection grain, fruit and water
    Alcohol Oxidase 162 37
    Alcohol detection brewing, fermentation, breath
    analysis
    Catalase
    22 37
    Cholesterol Oxidase 16 37
    Cholesterol level testing
    Choline Oxidase 15 37
    Choline esterase activity and phospholipids
    determination
    Diaphorase 150 37
    Hygene test (NADH, ATP)
    Fructose Dehydrogenase 155 4
    Fruit and wine analysis
    Fructose Dehydrogenase 155 25
    Galactose Oxidase 17 37
    sugar analysis in food
    β-Galactosidase 65 25
    Disease diagnosis for food allergies
    Glucose Dehydrogenase 13 37
    Glucose sensors healthcare and agrifood sector
    Glucose-6-Phosphate 150 37
    Dehydrogenase Hygene test
    Glutamate Dehydrogenase 665 22
    Ammonia in water, healthcare glutamate in food
    suffs and healthcare neurotransmitter analysis
    Glycerol-3-Phosphate Oxidase 37 15
    triglyceride analysis healthcare
    Hexokinase 150 37
    hygene test
    Horseradish Peroxidase 50 37
    glucose sensors healthcare and agrifood sectors
    β-Hydroxybutyrate 36 37
    Dehydrogenase detection of ketone bodies human healthcare
    Lactate Dehydrogenase 190 25
    animal healthcare and sport performance marker
    Lactate Oxidase 300 37
    animal healthcare and sport performance marker
    Malate Dehydrogenase 20 37
    Wine quality measurement and human healthcare
    NADH 182 22
    Any dehydrogenase based sensor or assay
    Pyruvate Kinase 150 37
    hygene testing and sports performance marker
    Serine Protease 56 66
    laundry products
    Uricase
    10 37
    uric acid determination human healthcare

    Matrix Nanobiosensor for the Detection of Toxic Gases:
    Carbon Monoxide (CO) Sensor:
  • The working electrode is composed of a nanostructured platinum material namely platinum nanoparticles or carbon nanotubes electroplated with platinum nanoparticles. The main reason for the employment of platinum as the working electrode is its known catalytic oxidation of carbon monoxide. The coating of the platinum nanoparticles onto the carbon nanotubes increases the surface catalytic activity of the working electrode towards CO yielding a higher sensitivity. The counter electrode is composed of a metal (e.g., platinum, gold, etc.) and the reference electrode (e.g., Ag/AgCl). The electrolyte constitutes a strong acidic electrolyte (e.g., M H2SO4), and the sensor is enclosed in a hydrophilic semi-permeable membrane.
  • The electrochemical reaction involving the detection of carbon monoxide using the sensor is,
  • Reaction at the sensing electrode: CO+H2O →CO2+2H++2e−
      • Reaction at the counter electrode: 1/2O2+2H++2e−→H2O
      • And the overall reaction: CO+ 1/2O2→CO2
  • The cyclic voltammogram of the oxidation of CO at platinum electrodes using the sensor is shown in FIG. 8, wherein the lower curve does not show a characteristic peak due to the absence of CO. When CO is exposed to the sensor, there is a characteristic oxidation peak at around 0.85 V. The proposed approach of the carbon nanotube-platinum nanoparticle composites will have a higher sensitivity and a lower oxidation potential as observed for the hydrogen peroxide sensors due to the involvement of carbon nanotubes. FIG. 9 describes the chronoamperometric response of the sensor to the exposure of CO. The sensor has a quick response time and provides reliable measurements since the oxidation peak of 0.85 V is characteristic towards the oxidation of CO by platinum.
  • The embodiments discussed above describe the fabrication of a nine element matrix for the development of nanobiosensors. The previous design electronics incorporated the individual driving of each sensor element along with the reference and counter electrodes. Though the design is a good development over the single element biosensor, there may be some difficulty extending this design for the development of n×n sensor elements. The previous design also incorporated a planar structure, wherein the reference, counter and working electrodes are in a silicon chip oriented on the X-Y plane. The nanobiosensor can be extended to detect hundreds of analytes if the biosensor substrate is linear. There is a requirement of an optimized design and electronic driving to extend the diversity of the nanobiosensors.
  • The following embodiments provide an alternative design to the nanobiosensors. Disclosed are the following:
  • 1) A linear design approach for the three electrode system (working, counter, reference electrodes).
  • 2) The specific placement of the reference electrode in close proximity of the working electrode in a single element and a matrix array form.
  • 3) The design of a semi-permeable, hydrophobic membrane on the area of the counter electrode, and design of the counter electrode in close proximity to the reference and working electrode in the electrolyte separate from the membrane. This is of high significance in the development of electrochemical gas sensors.
  • 4) Development of miniaturized electronics which enable the driving of the linear and matrix array elements. The sensor electronics enable cyclic voltammetric and chroamperometric measurements in the sensor without the standard laboratory based potentiostat.
  • 5) Design of an active matrix (analogous to the active matrix in liquid crystal displays) for the nanobiosensor application, which can enable the development of n×n sensor elements in a compact area. This invention is the first reported for the development of active matrix systems for the electrochemical (three electrode) systems. The electronics developed for the active matrix employs a shift register and can drive all the sensor elements in the active matrix.
  • Electrochemical sensors with three electrode systems (working, counter and reference electrodes) operate in an electrolyte coupled with an external potentiostat (see FIG. 3). Various designs have been reported for the electrochemical based sensors, but limited effort has been devoted to the development of array based sensors for the detection of multiple analytes. The problems with multi-sensor arrays are the cross-interference from other compounds, stability of the sensor element, etc. Biosensors have been reported using capture reagents. Devices and methods for detecting analytes using electrosensor having capture reagents, (World patent, WO0138873, 2001) but limited to the detection of a single analyte. Though different nanoscale materials like nanotubes, nanowires, nanoparticles have been used as substrates or binding agents, there has been a lack of a unified approach for the development of a matrix nanobiosensor, capable to multi-analyte detection. The electrochemical biosensing technique has great diversity in the detection of both liquid and gaseous analytes with accuracy in comparison with optical, dielectric, capacitive, resistance based techniques. The specific interaction of the analyte with the biological agent can be monitored with time electrochemically in the disclosed invention.
  • U.S. Pat. No. 6,656,712 describes the attachment of proteins to carbon nanotubes by incubation, without stirring. The biological macromolecule in solution is attached to the carbon nanotubes closed at their ends, under suitable temperature and pH conditions. The present invention uses an approach for the attachment of macromolecules, enzymes, proteins, antibodies, aptamers, nucleic acids, antigens, DNA, aptamers, ribozomes that includes electropolymerization with a conducting polymer matrix. An array of such sensors can be carried out within a few minutes and gives a stable framework for the electrochemical/biochemical reactions. The present invention also provides an efficient method of detection of both gaseous and liquid analytes by the use of a hydrophobic, semi-permeable membrane. The electrolyte can be wet (liquid phase) or dry (nafion, nanostructured silica, hydrogels and others) for the detection of chemical, biological warfare agents, gas detection, metabolic monitoring and other applications.
  • Linear Array Nanobiosensor:
  • A design of a linear nanobiosensor in accordance with an embodiment of the present invention is shown in FIGS. 10, 11A and 11B. FIG. 11A is a top view, while FIG. 11B is a partial cross-sectional view of one of the electrode assemblies illustrated in FIG. 10. As described above, the sensor element is comprised of carbon nanotubes 1100, and conducting polymer and biological enzymes 1101. The sensing element is the working electrode 1104 supported on a silicon substrate 1110; other substrates like plastic (polymeric), glass, ceramic, ITO, kapton and printed circuit boards may also be used. An insulating layer used over the bare substrate can be metal nitride, metal oxide, polymer, etc. The reference electrode 1103 can be made up of Ag/AgCl (silver, silver chloride), SCE (standard calomel electrode), SHE (standard hydrogen electrode) or other standard reference electrodes. The counter electrode 1102 can be a conductive layer like gold, silver, copper, titanium, platinum, chromium, aluminum, etc. In the linear structure, insulating supports (not shown) may be provided to separate the reference 1103, working 1104 and counter 1102 electrodes, since it is necessary for the three electrodes to be separated from each other during the electrochemical process. The invention provides an efficient way for the detection of liquid and gaseous analytes. The gas sensor may use an enclosed semi-permeable, hydrophobic membrane (not shown), which can also be permi-selective to distinguish between different gases (electron donors and electron acceptors). The membrane can be incorporated on the counter/working electrode or can be separated from the system. The purpose of the membrane is to allow a one way entry for the gas into the working electrode for the electrochemical reaction. It is understood that the purpose of the reference electrode 1103 in the three electrode system is to maintain a stable potential around the working electrodes 1104.
  • FIGS. 10, 11A and 11B provide a design wherein the counter electrode 1102 is placed in the top of the linear system. It is generally desirable to place the counter electrode 1102 far from the working electrode 1104, with an area at least ten times that of the working electrode.
  • Active Matrix Array Nanobiosensor:
  • Active matrix circuits have been previously employed in liquid crystal displays (Azuma, Seiichiro, “Fabrication of Thin-Film Transistor for Active-Matrix Liquid-Crystal Display,” Patent: JP 2003100639, 2003; Hebiguchi, Hiroyuki, “Active Matrix Type LCD In Which a Pixel Electrodes Width Along a Scanning Line is Three Times Its Data Line Side Width,” U.S. Pat. No. 6,249,326, 2001). The effectiveness of the matrix nanobiosensor can be enhanced by employing a row-column addressable array which enables the development of an n×n matrix that can be fabricated in a cost effective and miniaturized fashion. FIG. 12 shows the top view of an exemplary 3×3 matrix array incorporating nine working electrodes (W11 to W33) (as described above with respect to FIG. 11), with each working electrode configuration driven by a row and a column driver (see FIG. 14). For example, the working electrode W11 is driven by row 1 (R1) and column 1 (C1). The sensor element (each working electrode configuration) also incorporates an active element (AC) for the row-column addressing, wherein R1 and C1 should be “turned on” to activate the working electrode W11. The active matrix array design enables simultaneous driving of the multiple working electrodes, which cannot be achieved in the linear array design. For example, the voltage sweep of −1V to +1V at a scan rate of 50 mV/s in a cyclic voltammetric process takes 80 seconds for one electrode. The design shown in FIG. 2, wherein the working electrodes are arranged in a linear fashion, it would take 12 minutes to read the response of nine analytes. This presents a considerable disadvantage while sensing multiple analytes. FIG. 14 describes an active matrix configuration wherein the simultaneous driving of the working electrodes considerably shorten the time of detection. (For example, 80 seconds operating with cyclic voltammetry within the voltage sweep of −1V to +1V at a scan rate of 50 mV/s)”. This design provides considerable room for multiplexing the sensor elements and also for miniaturization of hundreds of sensor elements with microfabrication techniques. The active element (AC) is made up on an electrical circuit that can incorporate different configurations as shown in FIG. 13. The active circuit can constitute two diodes (FIG. 13 a), a diode with a resistor connected to the capacitor (FIG. 13 b), or a transistor (FIG. 13 c). The invention is not limited to the above described active matrix components, but can be extended to any “active” electronic circuit that can address the row-column operation for the matrix array nanobiosensor. For any working electrode configuration (Wxy) shown in FIG. 13, the active matrix should be connected to a row (Rx) and column (Cy) as shown in FIG. 12.
  • The active working electrode components should incorporate the reference and the counter electrodes (see FIG. 11) for the electrochemical reactions. The electrochemical techniques include but are not limited to cyclic voltammetry, chronoamperometry, differential pulse voltammetry, linear sweep voltammetry, stripping voltammetry, AC voltammetry, AC impedance, etc. The sensor can be used to detect the analyte also by amperometric, potentiometric, conductometric, voltammetric methods or combinations thereof. FIG. 14 shows a cross-section view of an n×n array matrix nanobiosensor with the row 1401 and column 1402 drivers. The structure incorporates an n×n array of working electrodes 1104, each element incorporating the specific carbon nanotube 1100, conducting polymer, enzyme combination 1101 as described previously. This invention is not limited to the above mixture of components mentioned above but can be employed with carbon (all forms), noble metals (gold, platinum, etc.) and proteins, antibodies, nucleic acids (DNA, RNA), peptides, aptamers, aptazymes, proteins along with the different conducting polymer combinations.
  • Drive Electronics:
  • The drive electronics for the matrix array nanobiosensor is shown in FIG. 15. The active matrix array nanobiosensor incorporates a shift register 1401 that couples to the n×n array of working electrodes 1104 that is coupled to data in, clock and an enable. The working electrode arrays are coupled to a current to voltage (I/E) converter 1402, the reference electrodes to an electrometer circuit 1403 that is coupled to a control amplifier 1404 connected to the counter electrode 1102. The different components of the electronic circuit for the linear array sensor are similar to that described in FIG. 3. The reference electrodes 1103 are shown interdigitated with the working electrodes 1104, but different configurations are possible and are not limited to the invention. The voltage sweep typically used is around −1 V to +1 V with a scan rate of 50 mV with a step of 1 mV, though other voltage windows, scan rate and step sizes can be used for cyclic voltammetric measurements. The multi-channel output from the n×n arrays is coupled to a display device (not shown) or an alarm (not shown) to indicate the presence of the analyte. The design shown in FIG. 15 can be altered to drive n×n sensor elements simultaneously by building miniaturized circuitry (electrometer, I/E converter, control amplifier) for each of the sensor elements. The row and column drivers shown in FIG. 14 are addressable to any X-Y element in the sensor matrix. Each of the active elements 1405 (AC) can be controlled by a switch 1406 through the row-column addressing.
  • Although the present invention and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (11)

1. A method of detecting multiple analytes using an array of nanobiosensors, wherein a plurality of nanobiosensors in the array have unique biological entities immobilized onto carbon nanotubes.
2. The method as recited in claim 1, wherein a first one of the plurality of nanobiosensors has a first biological entity immobilized onto carbon nanotubes, and wherein a second one of the plurality of nanobiosensors has a second biological entity immobilized onto carbon nanotubes, the first biological entity is unique relative to the second biological entity.
3. The method as recited in claim 2, wherein each nanobiosensor includes a working electrode having a biological entity immobilized onto carbon nanotubes, a reference electrode, and a counter electrode.
4. The method as recited in claim 3, wherein the electrodes are connected to circuitry for scanning each of the nanobiosensors.
5. An apparatus for detecting multiple analytes comprising an array of nanobiosensors, each comprising a biological entity immobilized onto carbon nanotubes.
6. The apparatus as recited in claim 5, wherein a plurality of the nanobiosensors in the array have unique biological entities.
7. The apparatus as recited in claim 6, wherein a first one of the plurality of nanobiosensors has a first biological entity immobilized onto carbon nanotubes, and wherein a second one of the plurality of nanobiosensors has a second biological entity immobilized onto carbon nanotubes, the first biological entity is unique relative to the second biological entity.
8. The apparatus as recited in claim 7, wherein each nanobiosensor includes a working electrode having a biological entity immobilized onto carbon nanotubes, a reference electrode, and a counter electrode.
9. The apparatus as recited in claim 8, wherein the electrodes are connected to circuitry for scanning each of the nanobiosensors.
10. The apparatus as recited in claim 8, wherein the reference electrode is in close proximity of the individual working electrodes and arranged in an active matrix configuration.
11. The apparatus as recited in claim 8, wherein the multiple working electrodes configured in an active matrix can be driven simultaneously to detect multiple analytes.
US11/011,645 2003-12-15 2004-12-14 Matrix array nanobiosensor Abandoned US20050244811A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US11/011,645 US20050244811A1 (en) 2003-12-15 2004-12-14 Matrix array nanobiosensor
KR1020067013860A KR20070004572A (en) 2003-12-15 2004-12-15 Matrix array nanobiosensor
PCT/US2004/042021 WO2005074467A2 (en) 2003-12-15 2004-12-15 Matrix array nanobiosensor
JP2006544124A JP2007513357A (en) 2003-12-15 2004-12-15 Matrix array nanobiosensor
EP04821308A EP1706130A4 (en) 2003-12-15 2004-12-15 Matrix array nanobiosensor
TW94143909A TWI406940B (en) 2004-12-14 2005-12-12 Matrix array nanobiosensor

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US52968303P 2003-12-15 2003-12-15
US53181903P 2003-12-22 2003-12-22
US10/952,669 US7399400B2 (en) 2003-09-30 2004-09-29 Nanobiosensor and carbon nanotube thin film transistors
US11/011,645 US20050244811A1 (en) 2003-12-15 2004-12-14 Matrix array nanobiosensor

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/952,669 Continuation-In-Part US7399400B2 (en) 2003-09-30 2004-09-29 Nanobiosensor and carbon nanotube thin film transistors

Publications (1)

Publication Number Publication Date
US20050244811A1 true US20050244811A1 (en) 2005-11-03

Family

ID=34841867

Family Applications (1)

Application Number Title Priority Date Filing Date
US11/011,645 Abandoned US20050244811A1 (en) 2003-12-15 2004-12-14 Matrix array nanobiosensor

Country Status (5)

Country Link
US (1) US20050244811A1 (en)
EP (1) EP1706130A4 (en)
JP (1) JP2007513357A (en)
KR (1) KR20070004572A (en)
WO (1) WO2005074467A2 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050265914A1 (en) * 2002-03-18 2005-12-01 Honeywell International, Inc. Carbon nanotube-based glucose sensor
US20060021881A1 (en) * 2003-09-30 2006-02-02 Nano-Proprietary, Inc. Nanobiosensor and carbon nanotube thin film transistors
US20060252143A1 (en) * 2005-05-05 2006-11-09 Lsi Logic Corporation High resolution semiconductor bio-chip with configuration sensing flexibility
US20070099351A1 (en) * 2005-10-31 2007-05-03 Peters Kevin F Sensing system
US20070158209A1 (en) * 2006-01-05 2007-07-12 Samsung Electronics Co., Ltd. Gas sensor and method thereof
WO2007147475A1 (en) * 2006-06-19 2007-12-27 Roche Diagnostics Gmbh Amperometric sensor and method for its manufacturing
US20080128285A1 (en) * 2006-12-04 2008-06-05 Electronics And Telecommunications Research Institute Electrochemical gas sensor chip and method of manufacturing the same
US20090155816A1 (en) * 2006-04-04 2009-06-18 Seoul National University Industry Foundation Biosensor having nano wire for detecting food additive mono sodium glutamate and manufacturing method thereof
US20090179093A1 (en) * 2006-06-08 2009-07-16 Sumio Wada Electrostatically atomizing device
US7732805B2 (en) * 2007-05-16 2010-06-08 Dongbu Hitek Co., Ltd. Image sensor and method for manufacturing the same
US7774038B2 (en) * 2005-12-30 2010-08-10 Medtronic Minimed, Inc. Real-time self-calibrating sensor system and method
US20100323925A1 (en) * 2002-03-15 2010-12-23 Gabriel Jean-Christophe P Nanosensor array for electronic olfaction
US20110163296A1 (en) * 2006-01-26 2011-07-07 Pace Salvatore J Cnt-based sensors: devices, processes and uses thereof
US20120118761A1 (en) * 2009-07-17 2012-05-17 Health Sciences University Of Hokkaido Method for electric measurement of peroxide using cnt sensor
US20120282602A1 (en) * 2011-05-02 2012-11-08 Ibis Biosciences, Inc. Multiple- analyte assay device and system
US8754454B2 (en) 2005-05-19 2014-06-17 Nanomix, Inc. Sensor having a thin-film inhibition layer
DE102013202003A1 (en) * 2013-02-07 2014-08-07 Siemens Aktiengesellschaft Direct, parallel determination of small molecular weight substances in a reactor broth using the cyclic voltammetry, comprises forming small molecular substances during a sequence of a biotechnological method in the reactor broth
US20150037900A1 (en) * 2012-04-19 2015-02-05 Cornell University Point of Care Cyanide Test Device and Kit
CN105067685A (en) * 2015-07-23 2015-11-18 武汉大学 Blood multi-component detection test paper and preparation method thereof
US9700252B2 (en) 2006-06-19 2017-07-11 Roche Diabetes Care, Inc. Amperometric sensor and method for its manufacturing
US9798886B2 (en) 2015-07-08 2017-10-24 International Business Machines Corporation Bio-medical sensing platform
WO2020004959A1 (en) * 2018-06-27 2020-01-02 광주과학기술원 Enzyme-based dissolved carbon monoxide sensor
EP3699613A4 (en) * 2017-10-18 2020-08-26 Sony Semiconductor Solutions Corporation Charge detection sensor and potential measuring system
US20210262966A1 (en) * 2018-06-27 2021-08-26 Gwangju Institute Of Science And Technology Enzyme-based dissolved carbon monoxide sensor
US20210386330A1 (en) * 2017-06-20 2021-12-16 Mohammad Abdolahad Real-time and label free analyzer for in-vitro and in-vivo detecting the suspicious regions to cancer
US11213226B2 (en) * 2010-10-07 2022-01-04 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
US11422106B2 (en) * 2019-02-19 2022-08-23 United States Government, as represented by the Administrator of the U.S. EPA Using 4-acetoxyphenol as a substrate for modular hydrolase biosensors

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2436619B (en) * 2005-12-19 2010-10-06 Toumaz Technology Ltd Sensor circuits
DE102006014713B3 (en) 2006-03-30 2007-11-15 Drägerwerk AG Electrochemical gas sensor
KR100777973B1 (en) * 2006-07-13 2007-11-29 한국표준과학연구원 Biosensor comprising interdigitated electrode sensor units
KR100824731B1 (en) * 2006-07-22 2008-04-28 고려대학교 산학협력단 Biosensor and method for preparing the same
WO2008018726A1 (en) 2006-08-07 2008-02-14 Seoul National University Industry Foundation Nanostructure sensors
MY173855A (en) * 2007-03-21 2020-02-25 Univ Putra Malaysia Amperometric biosensor for histamine determination
ES2310476B1 (en) * 2007-05-29 2009-11-17 Universitat Rovira I Virgili SELECTED ELECTRODES OF SOLID CONTACT IONS BASED ON CARBON NANOTUBES.
KR100928202B1 (en) * 2007-12-10 2009-11-25 한국전자통신연구원 Silicon biosensor and its manufacturing method
CN101587094B (en) * 2009-05-26 2012-05-23 上海大学 Method for concurrent measurement of dopamine and ascorbic acid using glassy carbon electrode
KR101258878B1 (en) * 2009-08-28 2013-04-30 한국전자통신연구원 The light addressing bio sensor chip and the driving method thereof
GB2480719B (en) * 2010-05-28 2012-10-24 Dra Ger Safety Ag & Co Kgaa Electrochemical gas sensor for, and method of, detecting prussic acid
DE102010021975B4 (en) * 2010-05-28 2020-01-16 Dräger Safety AG & Co. KGaA Electrochemical gas sensor and use of an electrochemical gas sensor for the detection of hydrocyanic acid
DE102010021977B4 (en) * 2010-05-28 2020-01-16 Dräger Safety AG & Co. KGaA Electrochemical gas sensor and use of an electrochemical gas sensor for the detection of ozone or nitrogen dioxide
KR101532112B1 (en) * 2011-06-14 2015-06-26 삼성전기주식회사 Bio chip
KR102217459B1 (en) * 2017-07-25 2021-02-25 주식회사 원바이오젠 Antibacterial polyurethane foam dressing
WO2019216460A1 (en) * 2018-05-10 2019-11-14 주식회사 나노바이오라이프 Diagnostic kit having grid-segmented transparent substrate, and optical diagnostic apparatus using same

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340458A (en) * 1980-06-02 1982-07-20 Joslin Diabetes Center, Inc. Glucose sensor
US20020012943A1 (en) * 1997-02-06 2002-01-31 Dana M. Fowlkes Electrochemical probes for detection of molecular interactions and drug discovery
US20020039743A1 (en) * 2000-09-29 2002-04-04 Koji Hashimoto Nucleic acid detection sensor
US20020086335A1 (en) * 1994-12-08 2002-07-04 Meso Scale Technology Llp Graphitic nanotubes in luminescence assays
US20020172963A1 (en) * 2001-01-10 2002-11-21 Kelley Shana O. DNA-bridged carbon nanotube arrays
US20030082444A1 (en) * 2001-10-26 2003-05-01 The Regents Of The University Of California Molehole embedded 3-D crossbar architecture used in electrochemical molecular memory device
US6592745B1 (en) * 1998-10-08 2003-07-15 Therasense, Inc. Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US20030207326A1 (en) * 2002-05-01 2003-11-06 Xing Su Methods and device for biomolecule characterization
US20040022677A1 (en) * 2001-06-29 2004-02-05 Favor Of Meso Scale Technologies, Llc Assay plates, reader systems and methods for luminescence test measurements
US20040261500A1 (en) * 2003-06-03 2004-12-30 Nano-Proprietary, Inc. Method and apparatus for sensing hydrogen gas
US6894359B2 (en) * 2002-09-04 2005-05-17 Nanomix, Inc. Sensitivity control for nanotube sensors
US6905655B2 (en) * 2002-03-15 2005-06-14 Nanomix, Inc. Modification of selectivity for sensing for nanostructure device arrays
US6918284B2 (en) * 2003-03-24 2005-07-19 The United States Of America As Represented By The Secretary Of The Navy Interconnected networks of single-walled carbon nanotubes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001043870A2 (en) * 1999-12-15 2001-06-21 Motorola Inc. Column and row addressable high density biochip array
JP3527185B2 (en) * 2000-09-01 2004-05-17 日本電信電話株式会社 Electrochemical measurement method of living tissue
JP2002195997A (en) * 2000-09-29 2002-07-10 Toshiba Corp Sensor for detecting nucleic acid
AU2002229046B2 (en) * 2000-12-11 2006-05-18 President And Fellows Of Harvard College Nanosensors
DE60144014D1 (en) * 2001-07-19 2011-03-24 Max Planck Gesellschaft Chemical sensors made from nanoparticle-dendrimer composite materials
KR100455284B1 (en) * 2001-08-14 2004-11-12 삼성전자주식회사 High-throughput sensor for detecting biomolecules using carbon nanotubes

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340458A (en) * 1980-06-02 1982-07-20 Joslin Diabetes Center, Inc. Glucose sensor
US20020086335A1 (en) * 1994-12-08 2002-07-04 Meso Scale Technology Llp Graphitic nanotubes in luminescence assays
US20020012943A1 (en) * 1997-02-06 2002-01-31 Dana M. Fowlkes Electrochemical probes for detection of molecular interactions and drug discovery
US6592745B1 (en) * 1998-10-08 2003-07-15 Therasense, Inc. Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US20020039743A1 (en) * 2000-09-29 2002-04-04 Koji Hashimoto Nucleic acid detection sensor
US20020172963A1 (en) * 2001-01-10 2002-11-21 Kelley Shana O. DNA-bridged carbon nanotube arrays
US20040022677A1 (en) * 2001-06-29 2004-02-05 Favor Of Meso Scale Technologies, Llc Assay plates, reader systems and methods for luminescence test measurements
US20030082444A1 (en) * 2001-10-26 2003-05-01 The Regents Of The University Of California Molehole embedded 3-D crossbar architecture used in electrochemical molecular memory device
US6905655B2 (en) * 2002-03-15 2005-06-14 Nanomix, Inc. Modification of selectivity for sensing for nanostructure device arrays
US20030207326A1 (en) * 2002-05-01 2003-11-06 Xing Su Methods and device for biomolecule characterization
US6894359B2 (en) * 2002-09-04 2005-05-17 Nanomix, Inc. Sensitivity control for nanotube sensors
US6918284B2 (en) * 2003-03-24 2005-07-19 The United States Of America As Represented By The Secretary Of The Navy Interconnected networks of single-walled carbon nanotubes
US20040261500A1 (en) * 2003-06-03 2004-12-30 Nano-Proprietary, Inc. Method and apparatus for sensing hydrogen gas

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100323925A1 (en) * 2002-03-15 2010-12-23 Gabriel Jean-Christophe P Nanosensor array for electronic olfaction
US20050265914A1 (en) * 2002-03-18 2005-12-01 Honeywell International, Inc. Carbon nanotube-based glucose sensor
US7955483B2 (en) * 2002-03-18 2011-06-07 Honeywell International Inc. Carbon nanotube-based glucose sensor
US9291613B2 (en) 2002-06-21 2016-03-22 Nanomix, Inc. Sensor having a thin-film inhibition layer
US20060021881A1 (en) * 2003-09-30 2006-02-02 Nano-Proprietary, Inc. Nanobiosensor and carbon nanotube thin film transistors
US7695609B2 (en) 2003-09-30 2010-04-13 Applied Nanotech Holdings, Inc. Nanobiosensor and carbon nanotube thin film transistors
US7399400B2 (en) 2003-09-30 2008-07-15 Nano-Proprietary, Inc. Nanobiosensor and carbon nanotube thin film transistors
US20080302676A1 (en) * 2003-09-30 2008-12-11 Nano-Proprietary, Inc. Nanobiosensor and carbon nanotube thin film transistors
US20060252143A1 (en) * 2005-05-05 2006-11-09 Lsi Logic Corporation High resolution semiconductor bio-chip with configuration sensing flexibility
US8754454B2 (en) 2005-05-19 2014-06-17 Nanomix, Inc. Sensor having a thin-film inhibition layer
US20070099351A1 (en) * 2005-10-31 2007-05-03 Peters Kevin F Sensing system
US7335526B2 (en) * 2005-10-31 2008-02-26 Hewlett-Packard Development Company, L.P. Sensing system
US9125607B2 (en) 2005-12-30 2015-09-08 Medtronic Minimed, Inc. Real-time self-calibrating sensor system and method
US9125608B2 (en) 2005-12-30 2015-09-08 Medtronic Minimed, Inc. Real-time self-calibrating sensor system and method
US8249683B2 (en) 2005-12-30 2012-08-21 Medtronic Minimed, Inc. Real-time self-calibrating sensor system and method
US7774038B2 (en) * 2005-12-30 2010-08-10 Medtronic Minimed, Inc. Real-time self-calibrating sensor system and method
US20070158209A1 (en) * 2006-01-05 2007-07-12 Samsung Electronics Co., Ltd. Gas sensor and method thereof
US7918989B2 (en) * 2006-01-05 2011-04-05 Samsung Electronics Co., Ltd. Gas sensor and method thereof
US8907384B2 (en) * 2006-01-26 2014-12-09 Nanoselect, Inc. CNT-based sensors: devices, processes and uses thereof
US20110163296A1 (en) * 2006-01-26 2011-07-07 Pace Salvatore J Cnt-based sensors: devices, processes and uses thereof
US20090155800A1 (en) * 2006-04-04 2009-06-18 Seoul National University Industry Foundation Biosensor having nano wire and manufacturing method thereof
US7927651B2 (en) * 2006-04-04 2011-04-19 Seoul National University Industry Foundation Biosensor having nano wire for detecting food additive mono sodium glutamate and manufacturing method thereof
US20090155816A1 (en) * 2006-04-04 2009-06-18 Seoul National University Industry Foundation Biosensor having nano wire for detecting food additive mono sodium glutamate and manufacturing method thereof
US8448883B2 (en) * 2006-06-08 2013-05-28 Panasonic Corporation Electrostatically atomizing device
US20090179093A1 (en) * 2006-06-08 2009-07-16 Sumio Wada Electrostatically atomizing device
US20090099433A1 (en) * 2006-06-19 2009-04-16 Arnulf Staib Amperometric sensor and method for its manufacturing
US8527024B2 (en) 2006-06-19 2013-09-03 Roche Diagnostics Operations, Inc. Amperometric sensor and method for its manufacturing
US9700252B2 (en) 2006-06-19 2017-07-11 Roche Diabetes Care, Inc. Amperometric sensor and method for its manufacturing
WO2007147475A1 (en) * 2006-06-19 2007-12-27 Roche Diagnostics Gmbh Amperometric sensor and method for its manufacturing
US20080128285A1 (en) * 2006-12-04 2008-06-05 Electronics And Telecommunications Research Institute Electrochemical gas sensor chip and method of manufacturing the same
US7732805B2 (en) * 2007-05-16 2010-06-08 Dongbu Hitek Co., Ltd. Image sensor and method for manufacturing the same
US20120118761A1 (en) * 2009-07-17 2012-05-17 Health Sciences University Of Hokkaido Method for electric measurement of peroxide using cnt sensor
US11213226B2 (en) * 2010-10-07 2022-01-04 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
CN103814122A (en) * 2011-05-02 2014-05-21 艾比斯生物科学公司 Multiple-analyte assay device and system
CN105699449A (en) * 2011-05-02 2016-06-22 艾比斯生物科学公司 Multiple-analyte assay device and system
US8614087B2 (en) * 2011-05-02 2013-12-24 Ibis Biosciences, Inc. Multiple-analyte assay device and system
US9835620B2 (en) 2011-05-02 2017-12-05 Ibis Biosciences, Inc. Multiple-analyte assay device and system
US9097711B2 (en) 2011-05-02 2015-08-04 Ibis Biosciences, Inc. Multiple-analyte assay device and system
US20120282602A1 (en) * 2011-05-02 2012-11-08 Ibis Biosciences, Inc. Multiple- analyte assay device and system
US20150037900A1 (en) * 2012-04-19 2015-02-05 Cornell University Point of Care Cyanide Test Device and Kit
DE102013202003A1 (en) * 2013-02-07 2014-08-07 Siemens Aktiengesellschaft Direct, parallel determination of small molecular weight substances in a reactor broth using the cyclic voltammetry, comprises forming small molecular substances during a sequence of a biotechnological method in the reactor broth
DE102013202003B4 (en) 2013-02-07 2022-08-25 Atspiro Aps Process and arrangement for the direct and parallel determination of small-molecular substances
US9798886B2 (en) 2015-07-08 2017-10-24 International Business Machines Corporation Bio-medical sensing platform
CN105067685A (en) * 2015-07-23 2015-11-18 武汉大学 Blood multi-component detection test paper and preparation method thereof
US20210386330A1 (en) * 2017-06-20 2021-12-16 Mohammad Abdolahad Real-time and label free analyzer for in-vitro and in-vivo detecting the suspicious regions to cancer
EP3699613A4 (en) * 2017-10-18 2020-08-26 Sony Semiconductor Solutions Corporation Charge detection sensor and potential measuring system
WO2020004959A1 (en) * 2018-06-27 2020-01-02 광주과학기술원 Enzyme-based dissolved carbon monoxide sensor
US20210262966A1 (en) * 2018-06-27 2021-08-26 Gwangju Institute Of Science And Technology Enzyme-based dissolved carbon monoxide sensor
KR102144082B1 (en) 2018-06-27 2020-08-12 광주과학기술원 Enzyme-based Dissolved Carbon Monoxide Sensor
KR20200001368A (en) * 2018-06-27 2020-01-06 광주과학기술원 Enzyme-based Dissolved Carbon Monoxide Sensor
US11422106B2 (en) * 2019-02-19 2022-08-23 United States Government, as represented by the Administrator of the U.S. EPA Using 4-acetoxyphenol as a substrate for modular hydrolase biosensors

Also Published As

Publication number Publication date
JP2007513357A (en) 2007-05-24
KR20070004572A (en) 2007-01-09
WO2005074467A2 (en) 2005-08-18
WO2005074467A3 (en) 2006-02-09
EP1706130A4 (en) 2008-01-09
EP1706130A2 (en) 2006-10-04

Similar Documents

Publication Publication Date Title
US20050244811A1 (en) Matrix array nanobiosensor
Urban et al. Miniaturized multi-enzyme biosensors integrated with pH sensors on flexible polymer carriers for in vivo applications
Pundir et al. Biosensing methods for determination of triglycerides: A review
KR100475634B1 (en) Biosensor equipped with sample introducing part which enables quick introduction of a small amount of sample
D O’Neill et al. Comparisons of platinum, gold, palladium and glassy carbon as electrode materials in the design of biosensors for glutamate
CN100457887C (en) Biological identification system with integrated sensor chip
CN107576707A (en) Analyte testing sensor and its system and the method for measuring at least one analyte
US20060180479A1 (en) Method, system and device for obtaining electrochemical measurements
Laschi et al. Planar electrochemical sensors for biomedical applications
Fang et al. A single-use, disposable iridium-modified electrochemical biosensor for fructosyl valine for the glycoslated hemoglobin detection
Amor-Gutiérrez et al. Bioelectroanalysis in a drop: Construction of a glucose biosensor
Galan-Vidal et al. Glucose biosensor strip in a three electrode configuration based on composite and biocomposite materials applied by planar thick film technology
Lata et al. Construction of amperometric l-amino acid biosensor based on l-amino acid oxidase immobilized onto ZnONPs/c-MWCNT/PANI/AuE
Albareda-Sirvent et al. Thick-film biosensors for pesticides produced by screen-printing of graphite–epoxy composite and biocomposite pastes
O’Reilly et al. Chronocoulometric determination of urea in human serum using an inkjet printed biosensor
EP3447483B1 (en) Novel biosensing technology based on enzymatic electrochemical impedance measurement
AU2007278327B2 (en) Electrochemical system for assaying a biological compound by an enzyme
Pemberton et al. Fabrication of microband glucose biosensors using a screen-printing water-based carbon ink and their application in serum analysis
Maciejewska et al. SECM imaging of spatial variability in biosensor architectures
TWI406940B (en) Matrix array nanobiosensor
KR101109857B1 (en) Electrochemical Biosensor Using Double Pulse Excitation
Matsumoto et al. A multilayer membrane amperometric glucose sensor fabricated using planar techniques for large-scale production
KR100533229B1 (en) Multi-layer electrochemical biosensor
Zhao et al. An Adhesive and Corrosion-Resistant Biomarker Sensing Film for Biosmart Wearable Consumer Electronics
US7319018B2 (en) Lactate biosensing strip with two electrodes

Legal Events

Date Code Title Description
AS Assignment

Owner name: NANO-PROPRIETARY, INC., TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SOUNDARRAJAN, PRABHU;GINSBERG, VALERIE;YANIV, ZVI;REEL/FRAME:016092/0649

Effective date: 20041214

AS Assignment

Owner name: APPLIED NANOTECH HOLDINGS, INC., TEXAS

Free format text: CHANGE OF NAME;ASSIGNOR:NANO-PROPRIETARY, INC.;REEL/FRAME:022211/0915

Effective date: 20080610

Owner name: APPLIED NANOTECH HOLDINGS, INC.,TEXAS

Free format text: CHANGE OF NAME;ASSIGNOR:NANO-PROPRIETARY, INC.;REEL/FRAME:022211/0915

Effective date: 20080610

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION